US 10342804
Steroid compound for use in the treatment of hepatic encephalopathy
granted A61KA61K31/198A61K31/216
Quick answer
US patent 10342804 (Steroid compound for use in the treatment of hepatic encephalopathy) held by Umecrine Cognition AB expires Mon Jul 04 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Umecrine Cognition AB
- Grant date
- Tue Jul 09 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 04 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K31/198, A61K31/216, A61K31/437, A61K31/4375